Citalopram vs Medroxyprogesterone: side-by-side comparison
Citalopram (Selective serotonin reuptake inhibitor (SSRI)) and Medroxyprogesterone (Progestin) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Citalopram | Medroxyprogesterone |
|---|---|---|
| Therapeutic class | Selective serotonin reuptake inhibitor (SSRI) | Progestin |
| CAS | 59729-33-8 | 520-85-4 |
| ATC | N06AB04 | G03DA02 |
| Molecular weight | 324.39 g/mol | 344.49 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Citalopram and Medroxyprogesterone share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Citalopram acts by a different mechanism than Medroxyprogesterone, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Citalopram: Le citalopram inhibe sélectivement le transporteur de recapture de la sérotonine, augmentant la disponibilité synaptique de la sérotonine avec une affinité limitée pour les transporteurs de la noradrénaline ou les autres… Medroxyprogesterone: La médroxyprogestérone se lie aux récepteurs de la progestérone et exerce de puissants effets progestatifs : épaississement de la glaire cervicale, inhibition de l'ovulation, amincissement de l'endomètre et réduction des…
Indications compared
Citalopram: Le citalopram est autorisé dans la dépression caractérisée. Medroxyprogesterone: La médroxyprogestérone est autorisée dans l'aménorrhée, les saignements utérins anormaux d'origine hormonale, la prévention de l'hyperplasie endométriale chez la femme ménopausée recevant un estrogène, et la prévention d…
Safety profile
Citalopram: Les effets indésirables fréquents comprennent nausées, sécheresse buccale, céphalées, troubles de la fonction sexuelle, troubles du sommeil et augmentation de la sudation. Medroxyprogesterone: Les effets indésirables fréquents de la forme orale comprennent saignements irréguliers, tension mammaire, variations de l'humeur, rétention hydrique et prise de poids.
Questions fréquentes
Is Citalopram better than Medroxyprogesterone? ▾
Citalopram and Medroxyprogesterone are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Citalopram and Medroxyprogesterone be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Citalopram
Products with Medroxyprogesterone
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.